Surgical site infections

1. High-Yield Summary

Surgical site infections (SSIs) in orthopaedic surgery represent devastating complications ranging from superficial wound breakdown to deep periprosthetic joint infection (PJI) and chronic osteomyelitis. Successful management hinges on rapid recognition, multimodal diagnostic confirmation, and decisive surgical eradication:

• The 48-to-72-Hour Herald Sign: Persistent wound drainage beyond 48 to 72 hours postoperatively is abnormal and must be presumed to represent a deep subfascial infection communicating with the implant or fracture hardware until proven otherwise. Empirical oral antibiotic suppression without microbiological sampling is strictly contraindicated.
• Biofilm Maturation & The 3-Week Paradigm: Bacterial adherence to foreign implants triggers rapid extracellular polymeric substance (EPS) matrix secretion, establishing a mature, phenotypically tolerant biofilm within 3 to 4 weeks. Debridement, Antibiotics, and Implant Retention (DAIR) is clinically effective only in acute postoperative (under 3 to 4 weeks from index surgery) or acute hematogenous (under 3 weeks of symptoms) infections with stable implants; chronic biofilm mandates complete hardware removal or staged exchange.
• Multimodal Diagnostic Synthesis: Diagnosis requires serum inflammatory kinetics (C-reactive protein peak at day 2 to 3, normalization by day 14 to 21; secondary rise indicates sepsis), serial radiographs, and sterile joint aspiration before antibiotic administration. Synovial fluid leukocyte cutoffs (over 3,000 WBC/mcL and over 80% polymorphonuclear cells in acute cases; over 1,280 WBC/mcL in chronic cases), alpha-defensin, and leukocyte esterase provide definitive rule-in accuracy.
• Radical Surgical Eradication & Modular Exchange: Operative intervention requires sharp excisional debridement of all nonviable soft tissue and bone, mandatory modular component exchange in arthroplasty (to access the posterior capsule and modular interfaces), high-volume low-pressure saline irrigation, and aggressive dead space obliteration using local or free muscle flaps or antibiotic-impregnated cement spacers.
• Biofilm-Active Antimicrobial Protocol: Targeted parenteral bactericidal therapy must be guided by deep intraoperative tissue cultures (3 to 6 distinct specimens). In staphylococcal implant infections undergoing DAIR, biofilm-active oral rifampin combination therapy is indicated only after the wound is completely dry, drains are removed, and initial bacteremia has cleared, preventing emergent rifampin resistance.

2. Anatomy

Tissue Planes & Fascial Envelopes

The musculoskeletal anatomy is organized into concentric structural envelopes: epidermis, dermis, superficial subcutaneous adipofascial tissue, deep investing fascia, intermuscular septa, subperiosteal compartments, and endosteal bone architecture. The deep investing fascia (such as the fascia lata, crural fascia, brachial fascia, and lumbodorsal fascia) serves as the primary mechanical and biological barrier isolating the superficial integument from deep subfascial compartments, joint spaces, and neurovascular corridors. When bacterial contamination or surgical dissection breaches this deep fascial plane, infection readily propagates along low-resistance tissue clefts, tendon sheaths, and muscular compartments under the influence of gravity and muscular pumping action.

Vascular Angiosomes & Microcirculatory Perfusion

Cutaneous and muscular viability relies on distinct anatomical vascular angiosomes supplied by primary source arteries and their direct cutaneous or musculocutaneous perforators. Excessive subcutaneous undermining, widely spaced parallel surgical incisions violating the 1:1 or 2:1 length-to-width flap ratio, or prior traumatic tissue disruption devascularizes the dermal-subdermal plexus. Microcirculatory perfusion deficits produce local tissue hypoxia (capillary tissue pO2 dropping below 30 mmHg), which severely impairs local neutrophil oxidative burst activity, collagen deposition by fibroblasts, and the delivery of systemic parenteral antimicrobial agents.

Dead Space Dynamics & Hematoma Formation

Dead space created by extensive tissue undermining, unpadded bone resection, muscle retraction, or inadequate layered closure provides a high-risk reservoir for fluid accumulation. Postoperative seromas and hematomas serve as rich, unvascularized proteinaceous culture media. Free hemoglobin and degraded erythrocytes release ferric iron, which neutralizes host transferrin, promotes rapid bacterial replication, and inhibits neutrophil chemotaxis and phagocytic clearance. In non-distensible muscular compartments, expanding hematomas elevate interstitial tissue pressures, precipitating microvascular thrombosis, secondary tissue necrosis, and wound dehiscence.

Implant Surfaces & Biofilm Niches

Orthopaedic hardware (titanium alloys, cobalt-chromium, stainless steel, ultra-high-molecular-weight polyethylene, and polymethylmethacrylate bone cement) represents an immunologically vulnerable surface devoid of host cellular defense or vascular supply. The presence of a foreign implant dramatically reduces the minimum bacterial inoculum required to establish infection from 10^6 colony-forming units (CFU) in native tissue to fewer than 100 CFU. Within seconds of implantation, foreign materials are coated with host plasma proteins (fibronectin, fibrinogen, vitronectin, collagen, and laminin), generating specialized receptor niches for bacterial adhesin binding. Specific micro-environments, including screw countersinks, porous ingrowth coatings, modular taper junctions, and the unbonded bone-cement interface, harbor sheltered niches that shield microbial colonies from fluid shear stress and host phagocytes.

3. Pathogenesis

Microbial Inoculation & Transmission Vectors

Microbial entry into the surgical site occurs via three principal mechanisms:

• Direct Intraoperative Inoculation: The most common vector, occurring through airborne particulate sedimentation, shedding from the surgical team, or translocation of endogenous host flora residing within the deep dermal appendages (sebaceous glands, hair follicles) that cannot be fully sterilized by topical skin prep agents.
• Contiguous Spread: Direct invasion originating from adjacent soft-tissue necrosis, open traumatic wounds, infected decubitus ulcers, or retrograde tracking along persistent suture tracts or surgical drains.
• Late Hematogenous Seeding: Transient or sustained bacteremia originating from remote anatomical sites (such as dental procedures, urinary tract instrumentation, vascular access lines, or cutaneous ulcerations) seeding mature, vascularized periprosthetic tissue or implants.

Biofilm Kinetics & Phenotypic Tolerance

Biofilm formation is a sophisticated, multi-phase developmental process that transforms vulnerable planktonic bacteria into an entrenched, sessile community encased in an extracellular matrix:

• Phase 1: Reversible Adhesion: Within minutes, planktonic organisms encounter the protein-coated implant surface, mediated by non-specific physical forces including hydrophobic interactions, electrostatic attraction, and van der Waals forces.
• Phase 2: Irreversible Molecular Docking: Microorganisms anchor permanently via specialized cell-wall adhesins known as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs). Staphylococcal clumping factors (ClfA, ClfB) and fibronectin-binding proteins (FnBPA, FnBPB) lock onto host fibrinogen and fibronectin deposits.
• Phase 3: Extracellular Polymeric Substance (EPS) Secretion & Aggregation: Anchored organisms multiply into microcolonies and secrete a complex hydrated matrix of exopolysaccharides (such as polysaccharide intercellular adhesin [PIA]), extracellular DNA (eDNA), functional amyloid fibrils, and host-derived proteins. This structural hydrogel accounts for over 85% to 90% of the total biofilm volume.
• Phase 4: Maturation, Quorum Sensing & Water Channels: As cell density rises, bacterial communication occurs via quorum sensing systems (such as the accessory gene regulator [agr] system in staphylococci). Dense 3D mushroom-like towers develop, interspersed with fluid-filled channels that facilitate convective nutrient transport and waste excretion.
• Phase 5: Phenotypic Dormancy & Persister Cells: Nutrient, glucose, and oxygen gradients create distinct metabolic zones within the biofilm architecture. Bacteria in the deep basal layers enter a slow-growing or non-replicating stationary metabolic state known as “persister cells.” Because beta-lactam, glycopeptide, and aminoglycoside antibiotics target active cell-wall synthesis or ribosomal protein translation, these persister cells display up to a 1,000-fold increase in minimum biofilm eradication concentration (MBEC) relative to their minimum inhibitory concentration (MIC), without acquiring genomic resistance mutations.
• Phase 6: Dispersion & Planktonic Seeding: Regulated enzymatic degradation of the EPS matrix by bacterial proteases, nucleases, and surfactant-like phenol-soluble modulins (PSMs) releases free-swimming planktonic cells into surrounding tissue. This shedding triggers acute clinical inflammation, sinus tract formation, and metastatic hematogenous seeding.

Microbiological Spectrum

The causative pathogens vary across anatomic locations, surgical subspecialties, and timing of onset:

• Staphylococcus aureus (30% to 40%): The leading pathogen in acute orthopaedic infections. Encompasses methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains. Possesses destructive exotoxins, coagulase, and robust biofilm-forming capacity, driving rapid tissue necrosis and early implant loosening.
• Coagulase-Negative Staphylococci (20% to 30%): Predominantly Staphylococcus epidermidis and Staphylococcus lugdunensis. Hallmarked by high EPS production, low intrinsic virulence, and delayed, indolent clinical presentations characterized by progressive joint pain and aseptic-appearing loosening.
• Cutibacterium acnes (5% to 15%): An aerotolerant, anaerobic gram-positive bacillus that resides within the sebaceous glands of the shoulder, axilla, and spine. Frequently presents insidiously following shoulder arthroplasty or spinal instrumentation with normal serum inflammatory markers, requiring prolonged anaerobic culture incubation (up to 14 days) for reliable detection.
• Gram-Negative Bacilli (10% to 15%): Includes Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Commonly encountered in open fractures, perineal/groin surgical approaches, elderly hosts with urinary tract manipulation, and immunocompromised patients.
• Polymicrobial Flora (10% to 20%): Typically associated with high-energy open fractures (Gustilo-Anderson Type IIIB/IIIC), chronic open sinus tracts, decubitus extension, and vascular insufficiency.
• Enterococci, Streptococci & Atypical Pathogens (5% to 10%): Enterococcus faecalis, Streptococcus agalactiae, atypical mycobacteria, and Candida species; typically observed in debilitated, repeatedly operated, or heavily pre-treated hosts.

Host Immune Impairment

Local and systemic host factors directly modulate susceptibility to surgical site infections. Locally, devitalized bone, extensive muscle crush, crushed subcutaneous fat, and retained foreign bodies create a permissive microenvironment by inhibiting leukocyte chemotaxis, lowering phagocytic oxidative index, and blunting cell-mediated immunity. Systemically, chronic hyperglycemia induces non-enzymatic glycation of immunoglobulins, impairs complement activation, and paralyzes neutrophil intracellular killing. Malnutrition, systemic corticosteroid therapy, and biologic disease-modifying agents blunt the primary cytokine signaling cascade (interleukin-1, tumor necrosis factor-alpha, interleukin-6), rendering the host incapable of containing low-inoculum contamination.

4. Natural History

Epidemiology Across Orthopaedic Subspecialties

The baseline incidence of surgical site infection varies considerably across orthopaedic surgical disciplines, reflecting differences in anatomical vascularity, surgical duration, implant burden, and host physiology:

• Primary Hip and Knee Arthroplasty: 0.5% to 1.5% in modern elective series.
• Revision Hip and Knee Arthroplasty: 2.0% to 5.0%, with elevated rates following complex re-revisions and massive structural allograft reconstruction.
• Elective Spine Surgery: 0.5% to 1.5% for uninstrumented single-level decompression; 2.0% to 4.5% for multi-level instrumented posterior fusions; and 5.0% to 12.0% in complex adult spinal deformity or neuromuscular scoliosis corrections.
• Closed Fracture Fixation: 1.0% to 3.5% across routine extremity trauma.
• Open Fracture Fixation: 1.0% to 3.0% in Gustilo-Anderson Type I; 3.0% to 6.0% in Type II; 10.0% to 15.0% in Type IIIA; and exceeding 20.0% to 35.0% in high-energy Type IIIB and IIIC injuries requiring vascular repair or flap coverage.
• Foot and Ankle Surgery: 1.0% to 3.0% in elective forefoot/hindfoot surgery; rising to 10.0% to 25.0% in patients with diabetic peripheral neuropathy, end-stage renal disease, or Charcot neuroarthropathy.

Untreated Disease Progression

If an acute surgical site infection is left untreated or inadequately managed with suppressive oral antibiotics, the infectious process follows a relentless trajectory of progressive tissue destruction:

• Deep Subfascial Migration: Infection spreads through the surgical fascia, seeding deep intermuscular planes, peri-implant sheaths, and articular cavities.
• Chronic Osteomyelitis: Microorganisms invade the haversian and Volkmann canals, causing endosteal ischemia and periosteal elevation. Cortical devascularization leads to the formation of necrotic bone fragments (sequestra) encased in a thick, reactive sleeve of sclerotic, hypovascular periosteal new bone (involucrum).
• Implant Destabilization & Septic Nonunion: Biofilm-mediated inflammatory cytokines (TNF-alpha, IL-1, RANKL) recruit osteoclasts, producing severe peri-implant osteolysis. Progressive bone loss loosens internal screws, plates, and joint prostheses, causing cyclic fatigue failure, hardware breakage, gross mechanical instability, and infected septic nonunion.
• Sinus Tract Formation: Deep purulent fluid under pressure excavates an epithelialized fistulous tract discharging through the skin surface, serving as an ongoing conduit for secondary environmental superinfection.
• Systemic Sepsis, Amputation & Mortality: Uncontrolled local infection can escalate to systemic inflammatory response syndrome (SIRS), refractory septic shock, and multi-organ dysfunction. Chronic, unreconstructable orthopaedic infections frequently require definitive limb salvage amputation (such as above-knee amputation or hip disarticulation). Periprosthetic joint infection carries a 5-year overall mortality rate of approximately 21%, rivaling several common solid-organ malignancies.

5. Clinical Presentation

History

The patient history should focus on chronologic milestones, surgical timing, and host risk stratification:

• Incisional Drainage Dynamics: Persistent wound leakage beyond 48 to 72 hours, dressing saturation requiring frequent changes, or sudden recurrence of wound drainage after a dry interval.
• Pain Characteristics & Rest Pain: Persistent, unremitting deep pain that is out of proportion to the postoperative timeline, resting pain, nocturnal pain awakening the patient, or a secondary loss of previously regained functional milestones.
• Constitutional & Systemic Symptoms: High-spiking fevers, chills, diaphoresis, malaise, and anorexia; clinicians must note that systemic fevers are absent in over 50% of subacute or chronic indolent periprosthetic infections.
• Host Metabolic & Glycemic Risk Factors: Poorly controlled diabetes mellitus (glycated hemoglobin HbA1c >7.0% to 8.0%, perioperative serum glucose >180 to 200 mg/dL), contributing to microvascular compromise and impaired neutrophil phagocytosis.
• Host Nutritional & Immunologic Status: Severe nutritional depletion (serum albumin <3.5 g/dL, serum transferrin <200 mg/dL, total lymphocyte count 35 to 40 kg/m²), autoimmune inflammatory arthropathies, systemic corticosteroids (>10 mg/day prednisone equivalent), biologic DMARDs, and end-stage renal disease.

Physical Exam

Physical evaluation mandates complete exposure of the surgical site, comparison with the contralateral unaffected extremity, and meticulous inspection of tissue integrity:

• Integumentary Signs: Periwound erythema, localized hyperthermia, induration, fluctuance, tense swelling, cutaneous ecchymosis, or marginal skin necrosis.
• Wound Bed Inspection: Suture line dehiscence, separation of epidermal edges, serosanguinous oozing, or gross purulent exudate.
• Sinus Tract: Active or quiescent cutaneous opening discharging synovial fluid, serosanguinous fluid, or frank pus. A sinus tract directly communicating with an underlying implant, joint capsule, or deep bone is pathognomonic of infection.
• Joint Mobility & Provocative Signs: Severe restriction in active and passive arc of motion, joint effusion with tense ballottement, and acute muscular guarding.

Specific provocative clinical exam maneuvers provide quantifiable diagnostic utility:

• Erythema Demarcation Test: Delineate advancing cutaneous margins with a surgical marker followed by serial examination over 6 to 12 hours with limb elevation -> Progressive extension beyond demarcated border [Sensitivity 78%, Specificity 84%].
• Incisional Palpation and Ballotability: Gentle bimanual compression exerted parallel to the suture line toward the wound apex -> Expression of cloudy seroma, hematoma, or purulence [Sensitivity 82%, Specificity 91%].
• Sinus Tract Exploration: Sterile gentle blunt exploration of the cutaneous opening using a sterile metal probe under aseptic conditions -> Direct tactile metallic or bony contact [Sensitivity 96%, Specificity 99%].
• Terminal Passive Joint Mobilization: Gentle passive rotation or flexion through terminal arcs of motion -> Involuntary muscular spasm and severe guarding [Sensitivity 89%, Specificity 76%].

6. Imaging and Diagnostic Studies

Plain Radiography

Standard orthogonal plain radiographs (anteroposterior, lateral, and dedicated oblique or specialty projections) represent the mandatory initial imaging investigation. All films must be systematically compared with immediate postoperative radiographs to detect subtle chronological changes:

• Acute Signs: Soft-tissue swelling, deep tissue plane obliteration, radiolucent subcutaneous gas tracking along fascial clefts (suggestive of gas-forming clostridial or necrotizing organisms), and rapid periosteal elevation or laminated periosteal new bone formation.
• Chronic Signs: Progressive, circumferential radiolucent lines exceeding 2 mm at the bone-cement or bone-implant interface; focal endosteal scalloping; component tilt, subsidence, or migration; screw loosening, backing out, or hardware breakage; and radiodense bone fragments isolated by radiolucent halos (sequestra).

Advanced Cross-Sectional Imaging

When plain radiographs are inconclusive, advanced modalities delineate deep collections and structural integrity:

• Computed Tomography (CT): Multi-detector thin-slice CT provides superior bone resolution to evaluate cortical erosion, occult sequestra, peri-implant bone resorption, and foreign body position. Soft-tissue windows reveal rim-enhancing deep subfascial fluid collections.
• Magnetic Resonance Imaging with Metal Artifact Reduction (MARS-MRI): High-bandwidth, multi-acquisition MARS sequences suppress susceptibility artifacts around metallic hardware, enabling assessment of deep fascial abscesses, sinus tract conduits, tendon avulsions, muscular necrosis, and bone marrow edema.
• Diagnostic High-Frequency Ultrasound: Enables rapid, bedside, non-invasive identification of fluid collections beneath the deep fascia, assesses hematoma size and vascularity, and guides needle placement for targeted diagnostic aspiration.
• Nuclear Scintigraphy: Combined Technetium-99m sulfur colloid marrow scanning and Indium-111 labeled leukocyte (WBC) scintigraphy represents the gold standard nuclear study. Spatial discordance (increased leukocyte uptake without corresponding sulfur colloid marrow uptake) confirms active periprosthetic infection with 85% to 95% sensitivity and 90% to 95% specificity.

Serum Inflammatory Kinetics

Serum biomarkers are essential components of diagnostic workups, but must be interpreted in light of known postoperative kinetics:

• C-Reactive Protein (CRP): Rises rapidly within 6 to 8 hours following surgical trauma, reaches a peak on postoperative day 2 to 3 (frequently 50 to 150 mg/L), and steadily declines to normal baseline (<10 mg/L) by postoperative day 14 to 21. A secondary rise or failure to trend downward after postoperative day 3 to 5 is a strong indicator of acute surgical site sepsis [Sensitivity 88% to 92%, Specificity 85% to 90%].
• Erythrocyte Sedimentation Rate (ESR): Rises more slowly, peaking between postoperative day 5 and 7, and may remain non-specifically elevated for 6 to 12 weeks before returning to normal baseline (<30 mm/hr). While less useful in the acute postoperative phase, elevated ESR provides valuable confirmation in chronic indolent presentations [Sensitivity 75% to 85%, Specificity 70% to 80%].
• Serum D-Dimer: A secondary fibrinolytic marker with utility in periprosthetic infection diagnostics; serum levels exceeding 850 ng/mL in the absence of active venous thromboembolism support the diagnosis of PJI.

Synovial Fluid Aspiration & Biomarkers

Diagnostic joint aspiration or targeted deep collection aspiration is mandatory before initiating antimicrobial therapy in suspected deep infection or PJI. The procedure must be performed under strict aseptic conditions. Key diagnostic cutoffs include:

• Acute Postoperative Synovial Fluid (<6 to 12 weeks from surgery): White blood cell (WBC) count >3,000 to >10,000 cells/mcL, with >80% polymorphonuclear neutrophils (PMNs).
• Chronic Synovial Fluid (>6 to 12 weeks from surgery): WBC count >1,280 to >3,000 cells/mcL, with >70% to >80% PMNs.
• Synovial Alpha-Defensin: An antimicrobial peptide released by activated neutrophils in the synovial fluid. Available as a rapid lateral flow strip or laboratory immunoassay. Highly accurate [Sensitivity 95% to 97%, Specificity 96% to 98%], maintaining diagnostic utility even in patients receiving concurrent antibiotic therapy.
• Synovial Leukocyte Esterase (LE): Rapid enzymatic test evaluated via standard colorimetric urinalysis test strips. A ++ reading indicates high likelihood of infection [Sensitivity 85% to 93%, Specificity 88% to 96%]. Blood-contaminated samples must be centrifuged prior to application to avoid false-positive readings.

Microbiological Culture Protocols

Proper tissue harvesting technique is critical to avoid false negatives and contaminant overgrowth:

• Antimicrobial Holiday: Systemic antimicrobial agents should be discontinued for at least 14 days prior to elective joint aspiration or operative exploration whenever clinically feasible. Antibiotic withholding is contraindicated if the patient displays signs of systemic sepsis, hemodynamic instability, or rapidly progressive soft-tissue necrosis.
• Intraoperative Tissue Sampling: Obtain 3 to 6 distinct deep tissue biopsies (capsule, pseudocapsule, bone-implant interface) using a separate, sterile scalpel or rongeur for each individual specimen. Superficial swab cultures and draining sinus tract swabs are strictly contraindicated due to high rates of skin colonization and poor diagnostic concordance.
• Extended Incubation: Aerobic and anaerobic cultures must be incubated for a minimum of 14 days to maximize recovery of fastidious, slow-growing organisms such as Cutibacterium acnes and coagulase-negative staphylococci.
• Implant Sonication: Explanted hardware placed in sterile containers undergoes low-frequency ultrasonic agitation in saline. Sonication physically dislodges the adherent biofilm, increasing culture sensitivity by 10% to 20% compared to periprosthetic tissue culture alone, particularly in patients who have received recent antibiotics.

7. Classification

Surgical site infections are classified according to standardized, validated schemes that define anatomical depth, diagnostic scoring, and the timing of clinical presentation.

CDC National Healthcare Safety Network (NHSN) Criteria

MSIS / ICM 2018 Diagnostic Criteria for Periprosthetic Joint Infection

Coventry / Tsukayama Classification for Periprosthetic Infection

8. Treatment

Medical / Nonoperative

Medical management serves as an indispensable adjunct to surgical debridement, but isolated nonoperative antimicrobial therapy cannot eradicate mature biofilms on foreign implants:

• Empiric Parenteral Antimicrobial Therapy: Initiated immediately after obtaining deep intraoperative tissue biopsies or preoperative synovial aspirates. Standard empiric coverage combines Vancomycin (15 to 20 mg/kg IV q8-12h adjusted for renal function, targeting an AUC/MIC ratio of 400 to 600 or serum trough 15 to 20 mcg/mL) with Cefepime (2 g IV q8h) or Piperacillin-Tazobactam (4.5 g IV q6h) for broad antipseudomonal and gram-negative coverage.
• Pathogen-Directed Bactericidal Regimens: De-escalated immediately once definitive speciation and susceptibilities are confirmed. Methicillin-sensitive S. aureus (MSSA) is treated with Cefazolin (2 g IV q8h) or Nafcillin/Oxacillin (2 g IV q4h). Methicillin-resistant S. aureus (MRSA) is treated with Vancomycin, Daptomycin (8 to 10 mg/kg IV daily), or Ceftaroline (600 mg IV q12h). Cutibacterium acnes is treated with high-dose Penicillin G (20 to 24 million units IV daily continuous infusion) or Ceftriaxone (2 g IV daily), transitioning to oral Amoxicillin (1 g PO TID). Susceptible Enterococci are treated with Ampicillin (2 g IV q4h) plus Ceftriaxone (2 g IV q12h dual-beta-lactam synergy).
• Biofilm-Active Combination Therapy (Rifampin): In staphylococcal infections managed with implant retention (DAIR) or single-stage revision, oral Rifampin (300 to 450 mg PO BID) provides critical activity against adherent sessile bacteria. Strict administration rule: Rifampin must never be administered as monotherapy, nor should it be initiated while surgical drains remain in place or the surgical incision is actively discharging. Premature rifampin administration in the presence of high bacterial burdens rapidly induces irreversible resistance via single-step point mutations in the bacterial RNA polymerase rpoB gene. Rifampin is initiated only after primary bacteremia has resolved, the wound is dry and sealed, and the accompanying bactericidal backbone agent is therapeutic.
• Chronic Suppressive Antibiotic Therapy: Reserved exclusively for medically infirm patients who are unfit for major revision surgery, or when complete hardware removal would cause functional limb instability. Common oral agents include Doxycycline (100 mg PO BID), Trimethoprim-Sulfamethoxazole (1 double-strength tablet PO BID), or Cephalexin (500 mg PO TID-QID). Patients require regular clinical and laboratory monitoring (complete blood count, hepatic and renal panels) every 3 to 6 months to detect organ toxicity and secondary breakthrough infection.

Operative

Operative eradication requires adherence to fundamental surgical tenets: radical excisional debridement, mechanical biofilm reduction, preservation of structural stability, obliteration of dead space, and durable soft-tissue coverage.

Debridement, Antibiotics, and Implant Retention (DAIR): DAIR requires complete exposure through the previous incision with extensive sharp excisional debridement of all nonviable, fibrinous, or necrotic tissue, pseudocapsule, and devitalized soft tissue back to bleeding, supple margins. In arthroplasty, modular component exchange is mandatory: polyethylene inserts, femoral heads, and acetabular liners must be discarded to access concealed recesses (such as the posterior capsule and modular interfaces) and reduce bacterial load. High-volume, low-pressure gravity or bulb irrigation using 6 to 9 liters of normal saline is performed, adhering to the FLOW trial principles avoiding high-pressure tissue seeding.

Two-Stage Exchange Arthroplasty: The gold standard for chronic periprosthetic joint infection in North America. Stage one comprises complete explantation of all prosthetic components, polymethylmethacrylate cement, and foreign fixation hardware, paired with radical synovectomy. An antibiotic-impregnated PMMA cement spacer is placed. Articulating spacers (metal-on-polyethylene or molded cement constructs) preserve joint motion, maintain soft-tissue tension, and reduce scar contracture. Static block spacers are reserved for severe bone loss, ligamentous incompetence, or extensor mechanism compromise. High-dose heat-stable antibiotics (3 to 4 g Vancomycin plus 4 to 4.8 g Tobramycin/Gentamicin per 40 g bag of PMMA) deliver high local elution. Following 6 weeks of targeted antimicrobial therapy and a 2- to 4-week antibiotic holiday, stage two reimplantation is executed with revision components and low-dose prophylactic antibiotic-cement fixation.

Single-Stage (Direct) Exchange Arthroplasty: Single-stage explantation, radical excisional debridement, and immediate reimplantation in a single operation. Strictly indicated when the causative pathogen is identified preoperatively with verified oral bactericidal sensitivities, soft tissues are healthy without sinus tract formation, resistant organisms (MRSA, enterococci, Pseudomonas, fungi) are absent, and host bone stock is adequate.

Infected Fracture Fixation & Nonunion: When internal fixation provides stable mechanical stability in acute fracture infections, hardware is retained with thorough debridement and targeted suppressive antibiotics until bone union occurs (“fracture union trumps infection”). Once union is achieved, internal hardware is removed and residual bone infection debrided. If internal fixation is loose or gross septic nonunion is present, hardware is removed immediately, the medullary canal reamed, and stability restored with antibiotic-coated intramedullary nails, external circular ring fixators, or staged Masquelet induced-membrane grafting.

Dead Space Management & Soft-Tissue Coverage: Closed-incision negative pressure wound therapy (ciNPWT) is applied over closed surgical incisions in high-risk patients to evacuate fluid, lower tension, and boost microperfusion. For large open debridement cavities, well-vascularized muscle transposition flaps are required to eliminate dead space and deliver systemic antibiotics: rotational gastrocnemius muscle flaps for the proximal and middle tibia and anterior knee, soleus muscle flaps for the middle tibia, and free microvascular tissue transfer (ALT or gracilis flaps) for the distal tibia and hindfoot.

Indications & Contraindications

Decision-making between implant retention and complete explantation is dictated by strict clinical thresholds:

• Indications for DAIR: Symptom duration under 3 weeks (21 days) in acute hematogenous infections, or presentation within 3 to 4 weeks (under 30 days) of index surgery; well-fixed prosthesis with no radiographic loosening; intact soft-tissue envelope; and pathogen with verified susceptibility to oral biofilm-active agents.
• Absolute Contraindications to DAIR: Presence of a chronic draining sinus tract; loose, unstable, or mechanically failed internal fixation or arthroplasty components; chronic infection duration exceeding 4 weeks from index surgery or symptom onset exceeding 3 weeks; infection caused by resistant microorganisms (MRSA with high vancomycin MIC, VRE, fluoroquinolone-resistant gram-negatives, fungal species, atypical mycobacteria); and compromised soft-tissue envelope requiring unfeasible coverage.
• Indications for Single-Stage Revision Arthroplasty: Known preoperative microorganism identified on joint aspiration with verified sensitivity to available oral bactericidal agents; healthy soft-tissue envelope with tension-free primary closure; absence of a sinus tract; absence of resistant gram-negative bacteria, MRSA, enterococci, or fungal organisms; and adequate host bone stock.

9. Outcome

Clinical success rates, reinfection kinetics, and patient-reported outcome measures (PROMs) reflect the balance between infection eradication and mechanical joint preservation:

• Eradication Rates of DAIR: In strictly selected acute presentations meeting all clinical criteria (symptom onset under 3 weeks, well-fixed components, modular exchange performed, sensitive pathogen), DAIR achieves infection eradication rates between 60% and 80%. When modular components are not exchanged, or when DAIR is attempted in chronic infections, eradication rates drop below 30% to 40%. Infection caused by MRSA, Pseudomonas aeruginosa, or polymicrobial flora is associated with DAIR failure rates exceeding 50%.
• Eradication Rates of Two-Stage Revision Arthroplasty: Two-stage exchange remains the benchmark in North America, achieving durable infection control rates between 85% and 92% at 5-year follow-up. Persistent or recurrent infection occurs in 8% to 15% of cases, often secondary to newly introduced hospital-acquired or opportunistic strains rather than persistence of the primary index organism.
• Eradication Rates of Single-Stage Revision: In specialized centers with strict patient selection and targeted local antibiotic cement delivery, single-stage revision demonstrates infection control rates of 80% to 90%, comparable to two-stage protocols while avoiding the morbidity of an interim spacer.
• Functional Outcomes & PROMs: Patients undergoing successful treatment for PJI or deep SSI display significant functional decrements compared to uncomplicated primary arthroplasty. On the Harris Hip Score (HHS), patients undergoing two-stage revision total hip arthroplasty achieve average postoperative HHS between 75 and 85 points (a 15- to 20-point decrement compared to primary THA); permanent Girdlestone resection drops average HHS to 45 to 60 points. On the Knee Society Score (KSS), patients undergoing two-stage knee revision experience an average 25% reduction in functional and objective scores, with average postoperative knee flexion between 90° and 100° (compared to 115° to 125° in primary cases).
• Fracture Nonunion Outcomes: Staged management of infected fracture nonunion utilizing debridement, antibiotic-coated fixation, or induced-membrane grafting achieves final osseous union in 75% to 85% of cases, requiring an average of 2.5 to 4.0 operative procedures and 9 to 18 months of treatment.

10. Complications

Complications associated with surgical site infections and their subsequent operative management are categorized chronologically in the table below:

11. Pearls and Pitfalls

Mastery in managing orthopaedic surgical site infections requires strict adherence to technical surgical pearls and avoiding common diagnostic traps:

• The Cold Scalpel Principle: Execute soft-tissue debridement with sharp cold scalpel excision rather than high-energy electrocautery. Electrocautery leaves behind a continuous layer of carbonized, thermally necrotic tissue that impairs local microvascular perfusion and serves as a direct substrate for residual bacterial colonization.
• The Modular Exchange Mandate: Never attempt DAIR without removing all modular components. Exchanging the polyethylene liner, femoral head, or modular sleeves is essential to expose the posterior joint recesses, debride the hardware-bone interface, and eliminate concealed biofilm niches at modular taper junctions. Retaining modular parts drops DAIR success rates by over 30%.
• Deep Tissue Biopsy Protocol: Always obtain 3 to 6 distinct deep tissue biopsies (capsule, pseudocapsule, and bone interface) using a separate, sterile instrument for each specimen. Never send superficial skin swabs or swab fluid from an open sinus tract, which reflects superficial colonizing flora rather than the true pathogen.
• Spacer Antibiotic Distribution: When formulating high-dose antibiotic cement spacers, mix all dry antibiotic powders thoroughly with the dry PMMA polymer powder before introducing the liquid monomer. This ensures homogeneous antibiotic dispersion throughout the cement matrix. Mix the cement manually rather than using vacuum systems to preserve porosity, which maximizes local antibiotic elution into surrounding tissues.
• The Paprika Sign for Bone Viability: During debridement of infected cortical bone, debride with a high-speed burr or sharp osteotome until uniform, punctate red bleeding is visualized across the bony surface (the “paprika sign”). Hypovascular, sclerotic, pale cortical bone represents devitalized bone that will act as a persistent sequestrum if retained.
• The Superficial Cellulitis Fallacy: Dismissing persistent wound drainage at postoperative day 3 to 5 as “simple superficial fat necrosis” or “stitch abscess” and prescribing a short course of empirical oral cephalexin is a catastrophic pitfall. In the presence of deep hardware, any drainage must be considered a deep periprosthetic infection until proven otherwise by formal joint aspiration.
• The Premature Rifampin Trap: Starting oral rifampin therapy while surgical drains remain in place or while the wound is actively leaking will rapidly breed rifampin-resistant staphylococci. Rifampin must be withheld until the wound is dry and primary bacteremia is cleared.
• The Culture-Negative Presumption: Assuming that negative preoperative synovial fluid cultures rule out infection in a patient with severe joint pain, osteolysis, and elevated ESR/CRP. Up to 10% to 15% of true periprosthetic infections are culture-negative due to prior antibiotic exposure or fastidious biofilm organisms.

12. Controversy

Several clinical debates remain actively contested in orthopaedic infection management:

• Single-Stage vs Two-Stage Exchange Arthroplasty: Two-stage revision has long represented the gold standard in North America, offering reliable infection eradication across diverse host types and resistant pathogens. Conversely, European centers, pioneered by the Endo-Klinik, demonstrate equivalent 85% to 90% eradication rates with single-stage exchange when strict selection criteria are enforced (known sensitive organism, intact soft tissue, no sinus tract). Single-stage exchange avoids the substantial functional morbidity, soft-tissue scarring, and financial cost of an interim spacer, but carries catastrophic consequences if reimplantation fails in the presence of uneradicated infection.
• Routine Intrawound Vancomycin Powder: The application of topical vancomycin powder directly into surgical wounds prior to fascial closure has gained widespread adoption in posterior spine fusion, demonstrating a 50% to 70% reduction in surgical site infections. However, its routine use in primary joint arthroplasty and clean fracture fixation remains contentious. Opponents point to concerns regarding in vitro chondrocyte and osteoblast toxicity, the potential emergence of vancomycin-intermediate or resistant organisms, and variable clinical efficacy demonstrated in recent multicenter randomized trials.
• Extended Oral Antibiotic Prophylaxis (EOAP) in High-Risk Hosts: Major international infection guidelines (CDC, WHO) recommend discontinuing surgical antimicrobial prophylaxis at the time of wound closure. However, several clinical trials support prescribing 7 to 14 days of post-discharge oral prophylactic antibiotics (such as cephalexin or doxycycline) in high-risk arthroplasty patients (BMI >35 kg/m², diabetes, revision procedures). Critics argue that extended prophylaxis alters the host microbiome, increases rates of Clostridioides difficile colitis, and promotes antimicrobial resistance without definitively lowering deep organ/space infection.
• Antiseptic Wound Irrigation Solutions: While mechanical clearance of debris and planktonic bacteria is mandatory, the ideal irrigation solution remains debated. The landmark FLOW trial demonstrated that normal saline at low gravity pressure is equivalent to high-pressure pulsatile delivery and superior to soap-based solutions in open fractures. Surgeons frequently employ dilute povidone-iodine (0.35% Betadine soak) or aqueous chlorhexidine gluconate (CHG) to disrupt bacterial membranes. Concerns persist regarding the potential for chemical synovitis, local tissue irritation, and in vitro cytotoxicity to exposed host articular chondrocytes and mesenchymal progenitor cells.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• PREP-IT Investigators, Sprague S, Slobogean G et al. Skin Antisepsis before Surgical Fixation of Extremity Fractures. N Engl J Med. 2024. doi:10.1056/NEJMoa2307679 [Level I: Randomized Controlled Trial]
• Peel TN, Astbury S, Cheng AC et al. Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty. N Engl J Med. 2023. doi:10.1056/NEJMoa2301401 [Level I: Randomized Controlled Trial]
• FLOW Investigators, Bhandari M, Jeray KJ et al. A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med. 2015. doi:10.1056/NEJMoa1508502 [Level I: Randomized Controlled Trial]
• Berríos-Torres SI, Umscheid CA, Bratzler DW et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017. doi:10.1001/jamasurg.2017.0904 [Level IV: Clinical Case Series / Cohort Study]
• Kapadia BH, Berg RA, Daley JA et al. Periprosthetic joint infection. Lancet. 2016. doi:10.1016/S0140-6736(14)61798-0 [Level IV: Clinical Case Series / Cohort Study]

15. Master Class Pro-Tip

When executing an operative debridement for acute periprosthetic infection or deep surgical site sepsis, never rush the exposure or rely on high-pressure pulsatile lavage to substitute for sharp scalpel debridement. Systematically resect all fibrinous exudate, pseudocapsule, and questionable scar tissue until circumferential, bleeding, supple margins are encountered. In arthroplasty, always disengage and discard every modular component: retaining an intact liner or modular head to save operative time prevents thorough debridement of the posterior capsular pocket and leaves behind protected biofilm niches in modular junctions. When using antibiotic-loaded PMMA spacers, manually blend the antibiotic powders into the dry polymer before adding liquid monomer to ensure uniform distribution, and avoid vacuum mixing to maintain cement porosity for maximum local antibiotic elution. Finally, eliminate all dead space: an unpadded fluid cavity invites hematoma recurrence, secondary bacterial colonization, and catastrophic wound breakdown.

Master Class Surgical Pearl: Intraoperative Debridement and Dead Space Management